PHARMACOGNOSTICAL, PHYSICOCHEMICAL AND CHROMATOGRAPHIC STANDARDIZATION OF SARIVADIGANA TABLET: AN AYURVEDIC POLYHERBAL FORMULATION

Introduction: Ardhavabhedaka is due to vitiation of Tridosha by Sushruta. It can be correlated with Migraine as it is characterized by one side or either side headache associated with nausea, vomiting. Rakta is the main dushya in shiroroga, because charaka has included Shiro-ruka in Raktapradoshaja Vikara. The Rasapanchaka of a drug helps break the pathogenesis of a disease by acting on the various factors involved in disease development. Sarivadi gana is Raktapittashamaka and selected for Ardhavabhedaka disease. Aim: To analyse the pharmacognostical and pharmaceutical properties of Sarivadigana tablet. Materials and methods: The formulation was prepared using authenticated raw drugs and subjected to pharmacognostical evaluation through organoleptic and microscopic studies. Pharmaceutical evaluation included hardness, weight variation, loss on drying, total ash, acid insoluble ash, water-soluble extractive, alcohol-soluble extractive and pH determination using standard analytical procedures. Thin Layer Chromatography (TLC) was performed to develop the chromatographic fingerprint profile of the formulation. Results: Organoleptic and microscopic studies confirmed the presence of characteristic diagnostic features of all the constituent drugs. The physicochemical analysis showed hardness of 4.48 ± 0.15 kg/cm², weight variation of 20 tablets 395.8 ± 15.79 mg, loss on drying 0.80 ± 0.03% w/w, total ash 5.79 ± 0.31% w/w, acid insoluble ash 1.40 ± 0.34% w/w, water-soluble extractive 17.16 ± 0.43% w/w alcohol soluble extractive 34.122 ± 0.30% w/w, and pH 6.00 ± 0.29. TLC fingerprinting revealed characteristic spots at both 254 nm and 366 nm, confirming the presence of multiple phytoconstituents in the formulation. Conclusion: The present study established preliminary pharmacognostical, physicochemical and chromatographic standards for Sarivadigana tablet. The findings may serve as useful reference parameters for the identification, quality assessment and standardization of the formulation.

• Agnivesha Charaka Samhita Vidyotini hindi commentary by pt Kashinathe Shastri and Dr. Gorakhanath Chaturvedi published by Chaukhambha Bharati Academy. Charaka SamhitaSidhisthana Chapter-9/75-76.
• Sushruta Samhita Sutrasthana 38/39-40 with Ayurveda Tatva Sandipika Hindi Commentary by Shastri A., Chaukhambha Sanskrit Sansthana, Varanasi 25.
• Wallis TE, Text book of Pharmacognosy, 5th Ed., New Delhi: CBS Publishers & Distributors, 2002; 210-215.
• Trease and Evans, Pharmacognosy, 15th Ed., W.B. Sunders Company Ltd., 1996; 569-570.
• Lachman L, Lieberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. 3rd ed. Philadelphia: Lea & Febiger, 1986.
• Indian Pharmacopoeia Commission. Indian Pharmacopoeia. 9th ed. Ghaziabad: Indian Pharmacopoeia Commission, 2022.
• Anonymous. The Ayurvedic Pharmacopoeia of India. Vol. I, Part II. Appendix 2, Section 2.2.10. 1st ed. New Delhi: Government of India, Ministry of Health and Family Welfare, 2007; 141.
• Anonymous. The Ayurvedic Pharmacopoeia of India. Vol. I, Part II. Appendix 2, Section 2.2.8. 1st ed. New Delhi: Government of India, Ministry of Health and Family Welfare, 2007; 141.
• Anonymous. The Ayurvedic Pharmacopoeia of India. Vol. I, Part II. Appendix 2, Section 2.2.7. 1st ed. New Delhi: Government of India, Ministry of Health and Family Welfare, 2007; 141.
• Anonymous, The Ayurvedic Pharmacopoeia of India, 1st ed, Govt. of India: Ministry of Health and Family Welfare; Part II, Vol. I, 2007: Appendix-2, (2.2.3), Pg. 140.
• Anonymous, The Ayurvedic Pharmacopoeia of India, 1st ed, Govt. of India: Ministry of Health and Family Welfare; Part II, Vol. I, 2007: Appendix-2, (2.2.4), Pg. 140.
• Anonymous. The Ayurvedic Pharmacopoeia of India. Vol. I, Part II. Appendix 3, Section 3.3. 1st ed. New Delhi: Government of India, Ministry of Health and Family Welfare, 2007; 191.
• Stahl E; Thin-layer chromatography a laboratory hand book. 2nd edition. Springer-Verlag New York, 1969; 125-133.
• Anonymous. The Ayurvedic Pharmacopoeia of India, Part 2. 1st ed., Vol. 1. New Delhi: Department of AYUSH, Ministry of Health and Family Welfare, Government of India, 2008; 140. 11.
• Anonymous. The Ayurvedic Pharmacopoeia of India. Appendices 1st ed. New Delhi: Govt. of India Publication, 2008; 2(2): 233-5.